NCT03549338 2020-09-28Sym004 Versus Futuximab or Modotuximab in Patients With mCRCSymphogen A/SPhase 2 Terminated2 enrolled 9 charts
NCT02568046 2019-03-26Sym004 in Combination With FOLFIRI in Metastatic Colorectal Cancer PatientsSymphogen A/SPhase 1/2 Terminated10 enrolled 14 charts